Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 VENUS REMEDIES   TEVA PHARMA
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
TEVA PHARMA
Dec-13
VENUS REMEDIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3793,479-   
Low Rs1453,022-   
Sales per share (Unadj.) Rs415.51,996.4-  
Earnings per share (Unadj.) Rs19.9124.7-  
Cash flow per share (Unadj.) Rs44.0286.1-  
Dividends per share (Unadj.) Rs0109.18-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs344.32,217.6-  
Shares outstanding (eoy) m13.37848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.61.6 38.7%   
Avg P/E ratio x13.226.1 50.6%  
P/CF ratio (eoy) x5.911.4 52.4%  
Price / Book Value ratio x0.81.5 51.9%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m3,5012,756,220 0.1%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m5700-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m5,5551,692,969 0.3%  
Other income Rs m1030-   
Total revenues Rs m5,6581,692,969 0.3%   
Gross profit Rs m602463,620 0.1%  
Depreciation Rs m323136,844 0.2%   
Interest Rs m333,253 0.0%   
Profit before tax Rs m379293,523 0.1%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m114-3,584 -3.2%   
Profit after tax Rs m266105,758 0.3%  
Gross profit margin %10.827.4 39.6%  
Effective tax rate %30.0-1.2 -2,454.1%   
Net profit margin %4.86.2 76.6%  
BALANCE SHEET DATA
Current assets Rs m3,2301,143,425 0.3%   
Current liabilities Rs m826997,163 0.1%   
Net working cap to sales %43.38.6 500.9%  
Current ratio x3.91.1 341.1%  
Inventory Days Days3791 40.7%  
Debtors Days Days50496 525.2%  
Net fixed assets Rs m2,781552,961 0.5%   
Share capital Rs m1344,167 3.2%   
"Free" reserves Rs m4,4700-   
Net worth Rs m4,6031,880,567 0.2%   
Long term debt Rs m387865,653 0.0%   
Total assets Rs m6,0113,868,976 0.2%  
Interest coverage x130.09.8 1,323.0%   
Debt to equity ratio x0.10.5 18.3%  
Sales to assets ratio x0.90.4 211.2%   
Return on assets %4.53.6 124.4%  
Return on equity %5.85.6 102.6%  
Return on capital %7.74.9 155.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m366269,772 0.1%  
From Investments Rs m-508-95,591 0.5%  
From Financial Activity Rs m-6-323,609 0.0%  
Net Cashflow Rs m-220-149,429 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare VENUS REMEDIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare VENUS REMEDIES With: GENNEX LAB.  TWILIGHT LITAKA PH.  FABINO LIFE   NEULAND LABS  SANJIVANI PA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.